Clinical Trials
7 trialsNCT04932525 2026-02-06
STING
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT04643418 2025-11-03
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
MegaPro Biomedical Co. Ltd.
Phase 1/2 Recruiting
NCT05723640 2025-09-08
The Safety and Dosimetry Study of 177Lu-LNC1004 Injection
Yantai LNC Biotechnology Singapore PTE. LTD.
Phase 1 Completed
NCT03628677 2025-02-04
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed
NCT06136065 2024-06-04
FAPI
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Unknown
NCT04976803 2022-08-01
ATM
Artios Pharma Ltd
Completed
NCT03318445 2021-03-04
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
University of California, San Francisco
Phase 1 Completed